| Line Item | 2026-05-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.8M | — | -1.3% |
| Cost of Revenue | $647K | — | +4.2% |
| Gross Profit | $1.2M | — | -4.0% |
| R&D Expense | $886K | — | -18.6% |
| SG&A Expense | $2.9M | — | -10.0% |
| Operating Income | -$2.7M | — | +14.8% |
| Interest Expense | $85K | — |
| Line Item | 2026-05-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $975K | -2.9% | +9.1% |
| Inventory | $1.4M | +4.6% | +20.2% |
| Current Assets | $3.0M | +2.4% | -9.6% |
| Total Assets | $9.1M | -2.4% | -7.0% |
| Current Liabilities | $44.9M | +125.0% | +534.3% |
| Total Liabilities |
| Line Item | 2026-05-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.8M | — | +16.9% |
| Capital Expenditures | $16K | — | +85.2% |
| Investing Cash Flow | -$16K | — | -69.1% |
| Financing Cash Flow | $2.8M | — | -1.0% |
| Free Cash Flow | -$2.8M | — | +16.7% |
| +48.3% |
| Net Income | -$5.7M | — | -24.4% |
| EPS (Basic) | -$0.02 | — | — |
| EPS (Diluted) | -$0.02 | — | — |
| $64.7M |
| +4.4% |
| +8.1% |
| Stockholders' Equity | -$56.1M | -5.4% | -11.1% |